Invus (Private Equity) Overview
- Investor Type
-
PE/Buyout
- Status
-
Active
- Professionals
-
54
- Investments
-
347
- Portfolio
-
95
- Exits
-
147
Invus (Private Equity) General Information
Company Description
Founded in 1985, The Invus Group is a private equity firm based in New York. The firm prefers to invest in consumer products and services, food, technology, life science, software, agtech, industrial, education, and medical devices sectors.
Business Details
Website
www.invus.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 750 Lexington Avenue
- 30th Floor
- New York, NY 10022
- United States
Invus (Private Equity) Investments (347)
Invus (Private Equity)’s most recent investment was a with Aclaris Therapeutics for . The deal was made on 28-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Aclaris Therapeutics | 28-Oct-2026 | Drug Discovery | Generating Revenue/Not Profitable | |||
| GenSight Biologics | 16-Oct-2026 | Biotechnology | Generating Revenue | |||
| Soufflé Therapeutics | 13-Oct-2026 | Therapeutic Devices | Pre-Clinical Trials | |||
| Matchpoint Therapeutics | 07-Oct-2026 | Biotechnology | Generating Revenue | |||
| North Immunology | 17-Sep-2026 | PIPE | Biotechnology | Generating Revenue |
Invus (Private Equity) Exits (147)
Invus (Private Equity) has made a total of 147 exits. Its latest exit was from Bambusa Therapeutics for on 30-Oct-2026. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Bambusa Therapeutics | 30-Oct-2026 | ||
| Lycia Therapeutics | 23-Oct-2026 | ||
| City Therapeutics | 15-Oct-2026 | ||
| ADARx Pharmaceuticals | 25-Sep-2026 | ||
| Cyclerion | 08-Sep-2026 | Merger/Acquisition |
Invus (Private Equity) Investments by Industry, Year, and Region
Invus (Private Equity) Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Invus Opportunities | New York, NY | 2007 | |
| Artal Asia | Singapore |
Invus (Private Equity) FAQs
-
What is Invus (Private Equity)?
Founded in 1985, The Invus Group is a private equity firm based in New York.
-
When was Invus (Private Equity) founded?
Invus (Private Equity) was founded in 1985.
-
Where is Invus (Private Equity) headquartered?
Invus (Private Equity) is headquartered in New York, NY.
-
What is Invus (Private Equity)'s total asset value?
Invus (Private Equity) has around in total assets under management.
-
How many investments has Invus (Private Equity) made?
Invus (Private Equity) has made 347 investments.
-
What has Invus (Private Equity) invested in?
Invus (Private Equity) has made numerous investments in companies like Aclaris Therapeutics, GenSight Biologics, and Soufflé Therapeutics within the Drug Discovery, Biotechnology, and Therapeutic Devices industries.
-
What has Invus (Private Equity) invested in recently?
Invus (Private Equity)'s latest investment was on 28-Oct-2026 in Aclaris Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process